Albemarle (ALB)
(Delayed Data from NYSE)
$100.84 USD
+0.91 (0.91%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $100.79 -0.05 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.84 USD
+0.91 (0.91%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $100.79 -0.05 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value B Growth F Momentum D VGM
Zacks News
Albemarle (ALB) Q2 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Strength in lithium and bromine businesses is expected to support Albemarle's (ALB) Q2 results.
Domtar Corp (UFS) Q2 Earnings Beat Estimates, Stock Up 2.2%
by Zacks Equity Research
Strong productivity helps Domtar Corp. (UFS) report better-than-expected second-quarter 2017 adjusted earnings.
Cosan Limited's (CZZ) Growth Potential Solid, Runs Risks
by Zacks Equity Research
We issued an updated research report on Cosan Limited (CZZ) on Jul 17, 2017.
7 Reasons that Make Chemours (CC) a Solid Choice Right Now
by Zacks Equity Research
Strong fundamentals, upbeat outlook and compelling growth prospects make Chemours an attractive choice for investment.
Albemarle Touches New 52-Week High on Solid Prospects
by Zacks Equity Research
Shares of chemicals maker Albemarle (ALB) scaled a fresh 52-week high of $117.13 on July 12.
Dow Chemical to Sell Certain Corn Seed Assets for $1.1B
by Zacks Equity Research
Dow Chemical (DOW) has reached an agreement to divest a part of its corn seed business in Brazil to CITIC Agri Fund for $1.1 billion.
6 Reasons to Add Koppers (KOP) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Koppers (KOP) has plenty of upside potential.
PolyOne Buys Mesa, Expands Color & Additives Offerings
by Zacks Equity Research
PolyOne (POL) has purchased Mesa, a North American producer of color and additive materials and services.
6 Reasons that Make Albemarle (ALB) a Solid Choice Now
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle an attractive choice for investment.
Eastman Chemical vs Albemarle: Which Stock Is a Better Pick?
by Zacks Equity Research
Which Zacks Rank #2 stock is better placed in terms of fundamentals - Eastman Chemical (EMN) or Albemarle (ALB)?
Top Analyst Reports for Procter & Gamble, Verizon & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Verizon (VZ) and Citigroup (C).
Albemarle (ALB) Up 4.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle Hits New 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Shares of premier specialty chemical company, Albemarle (ALB), scaled a new 52-week high of $114.29 yesterday, before pulling back to close the day at $113.60.
Is Albemarle (ALB) Stock a Solid Choice Right Now?
by Zacks Equity Research
Albemarle (ALB) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Albemarle (ALB) Scales New 52-Week High on Bright Prospects
by Zacks Equity Research
Albemarle (ALB) scaled a fresh 52-week high of $112.82 on May 15.
Albemarle (ALB) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Albemarle Corporation (ALB) recorded earnings of $51.2 million or 45 cents per share for the first quarter of 2017 compared with $228.2 million or $2.02 a year ago.
Will Univar (UNVR) Spring a Surprise this Earnings Season?
by Zacks Equity Research
Univar Inc. (UNVR) is slated to release first-quarter 2017 results ahead of the bell on May 5.
Should You Buy Albemarle (ALB) Ahead of Earnings?
by Zacks Equity Research
Albemarle (ALB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Delphi Automotive (DLPH) Q1 Earnings: Another Beat in Store?
by Zacks Equity Research
Delphi Automotive PLC (DLPH) is set to report first-quarter 2017 results on May 3.
Will Tesla's (TSLA) Q1 Earnings Beat on Higher Unit Sales?
by Zacks Equity Research
Tesla, Inc. (TSLA) is set to report first-quarter 2017 results after the market closes on May 3.
Albemarle (ALB) Q1 Earnings Preview: A Beat in the Cards?
by Zacks Equity Research
Albemarle (ALB) will release its first-quarter 2017 results after the bell on May 3.
Eastman Chemical (EMN) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Eastman Chemical (EMN) is set to release first-quarter 2017 results after the bell on Apr 27.
Dow Chemical (DOW) Q1: Can it Sustain the Earnings Streak?
by Zacks Equity Research
Dow Chemical (DOW) is scheduled to report its first-quarter 2017 results ahead of the bell on Apr 27.
U.S. Steel (X) Q1 Earnings Preview: Stock Poised to Beat?
by Zacks Equity Research
U.S. Steel (X) is set to release its first-quarter 2017 results after the bell on Apr 25.
DuPont (DD) Q1 Earnings: Can the Stock Spring a Surprise?
by Zacks Equity Research
DuPont (DD) is gearing up to release its first-quarter 2017 results ahead of the bell on Apr 25.